Thus, the presence of ICAM-1 and VCAM-1 can trigger an increase in the activated form of αL expressed on the surface of PB B cells in healthy donors, to levels already expressed on the B cells of patients with RA. Here, ICAM1 is linked to rheumatoid arthritis.